1-phenyl-3-(3,4,5-trimethoxyphenyl)propenone | 147729-57-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 1-phenyl-3-(3,4,5-trimethoxyphenyl)propenone
• 英文别名: 3-phenyl-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one；3-phenyl-1-(3',4',5'-trimethoxyphenyl)propan-1-one；3',4',5'-Trimethoxychalcone
• CAS: 147729-57-5
• 化学式: C₁₈H₁₈O₄
• 分子量: 298.339
• InChiKey: HJRVQVGPAQZDPJ-UHFFFAOYSA-N

物化性质

• 沸点：
  465.7±45.0 °C(Predicted)
• 密度：
  1.139±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-phenyl-3-(3,4,5-trimethoxyphenyl)propenone 在 四硝基甲烷 、 三乙胺 作用下， 以 1,4-二氧六环 为溶剂， 反应 2.0h， 以21%的产率得到4-nitro-3-phenyl-5-(3,4,5-trimethoxyphenyl)isoxazole
  参考文献：
  名称：

  NO / NO2介导的芳基取代的α，β-不饱和酮的杂环杂环合成4-硝基异恶唑

  摘要：

  通过用四硝基甲烷-三乙胺（TNM-TE​​A）络合物或叔-BuONO处理芳基/杂芳基取代的α，β-不饱和酮进行杂环化，已开发出一种合成4-硝基异恶唑的直接方法。该策略的特点是在简单的反应条件下具有高效率和广泛的底物耐受性。

  DOI：

  10.1055/s-0039-1690053
• 作为产物：
  描述：

  3',4',5'-三甲氧基苯乙酮 、 苯甲醛 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 生成 1-phenyl-3-(3,4,5-trimethoxyphenyl)propenone
  参考文献：
  名称：

  Bi（OTf）3催化肉桂醇歧化反应

  摘要：

  肉桂醇的Bi（OTf）3催化歧化反应可提供查耳酮和苄基苯乙烯。本文研究了各种金属三氟甲磺酸酯用于简便有效的氧化还原转化的用途。已经提出了一种合理的机制。

  DOI：

  10.1016/j.tet.2017.05.006

文献信息

• Structure−Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities
  作者：Balasubramanian Srinivasan、Thomas E. Johnson、Rahul Lad、Chengguo Xing

  DOI：10.1021/jm901278z

  日期：2009.11.26

  Chalcone is a privileged structure, demonstrating promising anti-inflammatory and anticancer activities. One potential mechanism is to suppress nuclear factor kappa B (NF-kappa B) activation. The structures of chalcone-based NF-kappa B inhibitors vary significantly that there is minimum information about their structure-activity relationships (SAR). This study aims to establish SAR of chalcone-based compounds to NF-kappa B inhibition, to explore the feasibility of developing simple chalcone-based potent NF-kappa B inhibitors, and to evaluate their anticancer activities. Three series of chalcones were synthesized in one to three steps with the key step being aldol condensation. These candidates demonstrated a wide range of NF-kappa B inhibitory activities, some of low micromolar potency, establishing that structural complexity is not required for NF-kappa B inhibition. Lead compounds also demonstrate potent cytotoxicity against lung cancer cells. Their cytotoxicities correlate moderately well with their NF-kappa B inhibitory activities, suggesting that suppressing NF-kappa B activation is likely responsible for at least some of the cytotoxicities. One lead compound effectively inhibits lung tumor growth with no signs of adverse side effects.
• One-pot synthesis of cinnamylideneacetophenones and their in vitro cytotoxicity in breast cancer cells
  作者：David J. Weldon、Marilyn D. Saulsbury、Joshua Goh、Leah Rowland、Petreena Campbell、Laijia Robinson、Calvin Miller、Joshua Christian、Louisa Amis、Nia Taylor、Cassandra Dill、Willie Davis、Stanley L. Evans、Eileen Brantley

  DOI：10.1016/j.bmcl.2014.05.089

  日期：2014.8

  A series of cinnamylideneacetophenones were synthesized via a modified Claisen-Schmidt condensation reaction and evaluated for cytotoxicity against breast cancer cells using the Alamar Blue (TM) assay. Derivatives 17 and 18 bearing a 2-nitro group on the B ring, exhibited sub-micromolar cytotoxicity in MCF-7 cells (IC50 = 71 and 1.9 nM), respectively. Derivative 17 also displayed sub-micromolar (IC50 = 780 nM) cytotoxicity in MDA-MB-468 cells. Additionally, 17 and 18 displayed significantly less cytotoxicity than the chemotherapeutic doxorubicin in non-tumorigenic MCF-10A cells. This study provides evidence supporting the continued development of nitro-substituted cinnamylideneacetophenones as small molecules to treat breast cancer. (C) 2014 Elsevier Ltd. All rights reserved.
• Carbonylative Heck Reactions Using CO Generated <i>ex Situ</i> in a Two-Chamber System
  作者：Philippe Hermange、Thomas M. Gøgsig、Anders T. Lindhardt、Rolf H. Taaning、Troels Skrydstrup

  DOI：10.1021/ol200686h

  日期：2011.5.6

  A carbonylative Heck reaction of aryl iodides and styrene derivatives employing a two-chamber system using a stable, crystalline, and nontransition metal based carbon monoxide source is reported. By applying near-stoichiometric amounts of the carbon monoxide precursor, an effective exploitation of the hazardous CO gas is obtained affording chalcone derivatives in good yields. Application to isotope labeling, incorporating (13)CO, was further established.
• Gallic acid-based indanone derivatives as anticancer agents
  作者：Hari Om Saxena、Uzma Faridi、Suchita Srivastava、J.K. Kumar、M.P. Darokar、Suaib Luqman、C.S. Chanotiya、Vinay Krishna、Arvind S. Negi、S.P.S. Khanuja

  DOI：10.1016/j.bmcl.2008.06.039

  日期：2008.7

  Gallic acid-based indanone derivatives have been synthesised. Some of the indanones showed very good anticancer activity in MTT assay. Compounds 10, 11, 12 and 14 possessed potent anticancer activity against various human cancer cell lines. The most potent indanone (10, IC50 = 2.2 mu M), against MCF-7, that is, hormone-dependent breast cancer cell line, showed no toxicity to human erythrocytes even at higher concentrations (100 mu g/ml, 258 mu M). While, indanones 11, 12 and 14 showed toxicities to erythrocytes at higher concentrations. (C) 2008 Elsevier Ltd. All rights reserved.
• Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines
  作者：Ashish Ranjan Dwivedi、Vijay Kumar、Harmeet Kaur、Naveen Kumar、Ravi Prakash Yadav、Ramarao Poduri、Somesh Baranwal、Vinod Kumar

  DOI：10.1016/j.bmcl.2020.127468

  日期：2020.10

  A series of triphenyl substituted pyrimidines as analogous of colchicine and combretastatin A-4 was synthesized and evaluated for the antiproliferative potential. The compounds were screened against MDA-MB-231, HCT-116 and HT-29 cell lines using MTT assay. Most of the compounds displayed antiproliferative activity in low to sub micro molar concentration. Amongst the synthesized derivatives, compounds HK-2, HK-10 and HK-13 were found to be effective against all the three cancer cell lines. HK-2 exhibited IC50 values of 3.39 mu M, 4.78 mu M and 4.23 mu M, HK-10 showed IC50 values of 0.81 mu M, 5.89 mu M, 4.96 mu M and HK-13 showed IC50 values 3.24 mu M, 4.93 mu M and 4.73 mu M against MDA-MB-231, HCT-116 and HT-29 cancer cell lines, respectively. HK-10 was found to be the most potent compound in the series with IC50 values of 0.81 mu M against MDA-MB-231. In the cell cycle analysis, HK-2 and HK-10 showed cell arrest at G2/M phase of the cell cycle while HK-13 inhibited cell growth at the G1/G0 phase. All the three compounds showed cell death induced through apoptosis. In the docking studies, HK-2, HK-10 and HK-13 were found to fit well in the colchicine binding site of the tubulin. Some of the compounds in the current series were found to be promising against all the three cancer cell lines and may act as potent leads for further development.